Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1976 Aug;10(2):322–324. doi: 10.1128/aac.10.2.322

Susceptibility of Haemophilus influenzae Type b to Cefatrizine, Ampicillin, and Chloramphenicol

Thomas Brotherton *, Tracy Lees *, Ralph D Feigin *
PMCID: PMC429742  PMID: 1086634

Abstract

The susceptibility of 269 isolates of Haemophilus influenzae type b to cefatrizine (BL-S640), ampicillin, and chloramphenicol was evaluated by disk diffusion susceptibility tests, using a modified Bauer-Kirby method. Broth dilution susceptibility tests were performed on 88 of these isolates, including all isolates resistant by disk to cefatrizine or ampicillin. Six of the isolates were resistant by disk to cefatrizine (zone size, <16 mm), four were resistant to ampicillin (zone size, <19 mm), and none were resistant to chloramphenicol (zone size, <17 mm). Only two of the six isolates of H. influenzae that were resistant to cefatrizine by disk were resistant to more than 4 μg of drug per ml. The four organisms resistant to ampicillin on disk were resistant, when tested by the broth method, to >128 μg/ml. These four ampicillin-resistant H. influenzae were susceptible to <4 μg of cefatrizine per ml. The two isolates resistant to >4 μg of cefatrizine per ml were susceptible to 0.5 and 2 μg of ampicillin, respectively, per ml. The activity of cefatrizine appears to be comparable in vitro to ampicillin against H. influenzae.

Full text

PDF
322

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Actor P., Uri J. V., Phillips L., Sachs C. S., Guarini J. R., Zajac I., Berges D. A., Dunn G. L., Hoover J. R., Weisbach J. A. Laboratory studies with cefatrizine (SK + F 60771), a new broad-spectrum orally-active cephalosporin. J Antibiot (Tokyo) 1975 Aug;28(8):594–601. doi: 10.7164/antibiotics.28.594. [DOI] [PubMed] [Google Scholar]
  2. Bauer A. W., Kirby W. M., Sherris J. C., Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966 Apr;45(4):493–496. [PubMed] [Google Scholar]
  3. Leitner F., Buck R. E., Misiek M., Pursiano T. A., Price K. E. BL-S 640, a cephalosporin with a broad spectrum of antibacterial activity: properties in vitro. Antimicrob Agents Chemother. 1975 Mar;7(3):298–305. doi: 10.1128/aac.7.3.298. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Leitner F., Chisholm D. R., Tsai Y. H., Wright G. E., Deregis R. G., Price K. E. BL-S640, a cephalosporin with a broad spectrum of antibacterial activity: bioavailability and therapeutic properties in rodents. Antimicrob Agents Chemother. 1975 Mar;7(3):306–310. doi: 10.1128/aac.7.3.306. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Overturf G. D., Ressler R. L., Marengo P. B., Wilkins J. In vitro evaluation of BL-S640, a new oral cephalosporin antibiotic. Antimicrob Agents Chemother. 1975 Sep;8(3):305–310. doi: 10.1128/aac.8.3.305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Watanakunakorn C., Bannister T., Glotzbecker C. Susceptibility of clinical isolates of Enterobacteriaceae to BL-S640, a new oral cephalosporin. Antimicrob Agents Chemother. 1975 Mar;7(3):381–385. doi: 10.1128/aac.7.3.381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Yourassowsky E., Schoutens E., Vanderlinden M. P. Comparative inhibitory activity of BL-S640 and two other cephalosporins. J Antibiot (Tokyo) 1975 Aug;28(8):590–593. doi: 10.7164/antibiotics.28.590. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES